ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Arecor Therapeutics Plc

Arecor Therapeutics Plc (AREC)

69.50
0.00
(0.00%)
Cerrado 21 Diciembre 10:30AM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
69.50
Postura de Compra
67.00
Postura de Venta
72.00
Volume Operado de la Acción
25,000
69.50 Rango del Día 72.00
62.50 Rango de 52 semanas 182.50
Capitalización de Mercado [m]
Precio Anterior
69.50
Precio de Apertura
69.50
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
8,669
Acciones en circulación
37,756,601
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-3.07
Beneficio por acción (BPA)
-0.23
turnover
5.72M
Beneficio neto
-8.55M

Acerca de Arecor Therapeutics Plc

Sector
Coml Physical, Biologcl Resh
Industria
Coml Physical, Biologcl Resh
Sitio web
Sede
London, Gbr
Fundado
-
Arecor Therapeutics Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker AREC. The last closing price for Arecor Therapeutics was 69.50p. Over the last year, Arecor Therapeutics shares have traded in a share price range of 62.50p to 182.50p.

Arecor Therapeutics currently has 37,756,601 shares in issue. The market capitalisation of Arecor Therapeutics is £26.24 million. Arecor Therapeutics has a price to earnings ratio (PE ratio) of -3.07.

AREC Últimas noticias

Arecor Therapeutics PLC Grant of Options and PDMR Dealing

Arecor Therapeutics PLC 02 December 2024     Arecor Therapeutics plc   ("Arecor" or "the Company")   Grant of Options and PDMR Dealing   Cambridge, UK, 2 December 2024: Arecor Therapeutics plc...

IN BRIEF: Arecor Therapeutics names David Ellam as interim CFO

cs PLC - biopharmaceutical company based in Little Chesterford, England - Announces hiring of David Ellam as interim c ...

Arecor Therapeutics PLC Arecor Appoints Interim Chief Financial Officer

Arecor Therapeutics PLC 18 November 2024     Arecor Therapeutics plc ("Arecor" or "the Company")   APPOINTMENT OF INTERIM CHIEF FINANCIAL OFFICER   Cambridge, UK, 18 November 2024: Arecor...

EARNINGS: Hansard Global profit down; Flowtech cuts outlook

The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported b ...

Arecor Therapeutics PLC Interim Results for six months ended 30 June 2024

Arecor Therapeutics PLC 26 September 2024   Arecor Therapeutics plc ("Arecor", the "Company" or the "Group")   INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024   -     AT278 insulin...

Arecor Therapeutics PLC Notice of Results

Arecor Therapeutics PLC 19 September 2024   Arecor Therapeutics plc ("Arecor" or the "Group")   NOTICE OF INTERIM RESULTS   Cambridge, UK, 19 September 2024: Arecor Therapeutics plc (AIM:...

Arecor Therapeutics PLC Arecor presents positive AT278 data at EASD

Arecor Therapeutics PLC 11 September 2024   Arecor Therapeutics plc ("Arecor", the "Company" or the "Group")   ARECOR PRESENTS POSITIVE DATA FROM PHASE I CLINICAL TRIAL OF ULTRA-CONCENTRATED...

Arecor Therapeutics PLC Holding(s) in Company

Arecor Therapeutics PLC 22 August 2024     TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-7-9.1503267973976.57862.51062569.15218824DE
4-7-9.1503267973976.57862.5356271.2660142DE
1222.9629629629667.57862.5866971.19459389DE
26-50.5-42.083333333312012062.5806077.75596449DE
52-113-61.9178082192182.5182.562.511341120.67864843DE
156-320.5-82.179487179539042062.56730180.35309158DE
260-168-70.7368421053237.546062.57578208.5818633DE

AREC - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Arecor Therapeutics?
El precio actual de las acciones de Arecor Therapeutics es 69.50p
¿Cuántas acciones de Arecor Therapeutics están en circulación?
Arecor Therapeutics tiene 37,756,601 acciones en circulación
¿Cuál es la capitalización de mercado de Arecor Therapeutics?
La capitalización de mercado de Arecor Therapeutics es GBP 26.24M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Arecor Therapeutics?
Arecor Therapeutics ha negociado en un rango de 62.50p a 182.50p durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Arecor Therapeutics?
El ratio precio/beneficio de Arecor Therapeutics es -3.07
¿Cuál es el ratio de efectivo a ventas de Arecor Therapeutics?
El ratio de efectivo a ventas de Arecor Therapeutics es 4.59
¿Cuál es la moneda de reporte de Arecor Therapeutics?
Arecor Therapeutics presenta sus resultados financieros en GBP
¿Cuál es el último ingresos anual de Arecor Therapeutics?
El último ingresos anual de Arecor Therapeutics es GBP 5.72M
¿Cuál es el último beneficio anual de Arecor Therapeutics?
El último beneficio anual de Arecor Therapeutics es GBP -8.55M
¿Cuál es la dirección registrada de Arecor Therapeutics?
La dirección registrada de Arecor Therapeutics es CHESTERFORD RESEARCH PARK, LITTLE CHESTERFORD, SAFFRON WALDE, LONDON, CB10 1XL
¿Cuál es la dirección del sitio web de Arecor Therapeutics?
La dirección del sitio web de Arecor Therapeutics es www.arecor.com
¿En qué sector industrial opera Arecor Therapeutics?
Arecor Therapeutics opera en el sector COML PHYSICAL, BIOLOGCL RESH

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TIRTiger Royalties And Investments Plc
0.15p
(50.00%)
3.41M
BAYBay Capital Plc
5.50p
(19.57%)
209.68k
MASTMast Energy Developments Plc
0.19p
(18.75%)
20.09M
MHNMenhaden Resource Efficiency Plc
148.50p
(18.33%)
1M
ZENZenith Energy Ltd.
2.50p
(16.28%)
3.93M
TRYBTribe Technology Plc
0.115p
(-79.09%)
24.27M
NMTNeometals Ltd
2.75p
(-35.29%)
49.4k
SNGSynairgen Plc
2.46p
(-34.31%)
4.31M
TM1Technology Minerals Plc
0.185p
(-26.00%)
174.03M
AYMAnglesey Mining Plc
0.70p
(-17.65%)
2.99M
NTVONativo Resources Plc
0.002p
(5.26%)
971.94M
TRPTower Resources Plc
0.035p
(9.38%)
620.03M
LLOYLloyds Banking Group Plc
54.16p
(-0.26%)
341.48M
ORCPOracle Power Plc
0.0255p
(-1.92%)
192.93M
TM1Technology Minerals Plc
0.185p
(-26.00%)
174.03M
joe botts joe botts 23 segundos hace
Holy! Great 6 year old news!
doc2016 doc2016 1 minuto hace
now, we seem to have ploinks and puddle on the new msft fabric which seems to incorporate much if not all of vcsy ip with 8 ip?...........anybody think this is what it would be all the time?

now i wonder how this sits with google whose android customers are likely lg, samsung, interwo
getmoreshares getmoreshares 2 minutos hace
Pink Limited Information
NTRR
learningcurve2020 learningcurve2020 2 minutos hace
Here's what pathological lying looks like, btw.  

https://www.breitbart.com/the-media/2024/12/20/nolte-breitbarts-liar-year-2024-award-goes-joe-scarborough/
NWBO
1vman 1vman 3 minutos hace
*****🟥🟥🟥 LOL ! now I am hearing 🟥nonsense🟥Kramer naked shorted DBMM

https://investorshub.advfn.com/uimage/uploads/2024/9/12/ypv[ilaughing-baby.gif

ENOUGH SAID HUZZAH🤪 !!!
DBMM
getmoreshares getmoreshares 3 minutos hace
Held at DTC 2,766,390,658
12/20/2024
DTC
tdbowieknife tdbowieknife 3 minutos hace
Lol... You would only get lies from Klug. The real information is posted here by me.

Right, Could Be 1...

..

.
1vman 1vman 4 minutos hace
***** NO SIR !!! 🚽UBQU🚽 Does not have 5 million in revenues , point in fact financials are not very good and can be found here

https://www.otcmarkets.com/stock/UBQU/disclosure

ENOUGH SAID 🤪 !!!
UBQU
tedpeele tedpeele 4 minutos hace
The answers are staring you all in the face

You can’t see it because you’re stubborn

Some things are too incongruent to ignore. For me the $5.2 million in cash bonuses was one of those things. There are many more, but that was the first thing I saw.

A h
ASM
1vman 1vman 6 minutos hace
*****💩HIRU💩 Historically has been a complete and utter Xpert failure

https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/historical

ENOUGH SAID🤔 !!! HUZZAH🤔 !!!
HIRU
GetSeriousOK GetSeriousOK 6 minutos hace
BIEL BUY RATING based on what?

Barchart uses TA, and TA doesn't work on BIEL because:

The corporation is forfeited in Maryland, its state of incorporation, for the second time in 30 months.

The CEO is the only officer left at this company. All the other o
TREET
DLucky6636 DLucky6636 7 minutos hace
Thx. I hope he moves to Denver. CEO full time remote with COO half time remote is not good for a mature company. For a pre-revenue "startup", it is just not acceptable. If JM wants to semi-retire, I don't blame him. He is at the age and has the money. But just don't hold the COO position. I ho
LWLG
Farmsara Farmsara 8 minutos hace
Spot on, Matt. It’s amazing how some on this board try to spin the December 2023 letter into being something that it wasn’t. No matter how many times I’ve read that letter, no one can convince me that a deal was not going to happen in the short term future based on the CEO’s very own words. Let’s ho
LWLG
learningcurve2020 learningcurve2020 9 minutos hace
Wow, that Advent sure has some operation! 🙄
Nice job pretending to see nothing wrong with it, btw.  
NWBO
TMaga TMaga 9 minutos hace
What was this 9 day meeting all about??? Send in an application for what??? Clinical trials(Can take years) Patent application (Can take up to one year) No guarantees, just a first step.
ADHC
mwab52 mwab52 9 minutos hace
Good morning (RNVA-Land & Team).......🤑😎......Go (RNVA & Team)
RNVA
AlwaysOptimistic AlwaysOptimistic 9 minutos hace
Tiny But Vital Metal Markets Rush to Adjust to Chinese Clampdown

https://finance.yahoo.com/news/tiny-vital-metal-markets-rush-133000810.html
NB
Stock Guy777 Stock Guy777 10 minutos hace
🙄🤦🏻‍♂️
HMBL
doc2016 doc2016 11 minutos hace
goodness, some ploinks and puddle for a monitoring tool and what/how to contain/treat an infestation or hint of one?

for msft teams feds/cisa have new rules...scuba......best practices . binding operational directive for federal civilian agencies...secure cloud business applications.
SkyLimit2022 SkyLimit2022 12 minutos hace
LC,

You raise a valid point about the website: They really should align the main page with the updates from their press releases. ✅️

Thanks for refocusing our attention on the significant developments that have unfolded since the landmark P3 concluded …
NWBO
OPKOHEALTH2022 OPKOHEALTH2022 12 minutos hace
Wethemarket, I found this :
https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title26-section45V&num=0&edition=prelim
FCEL
doc2016 doc2016 12 minutos hace
maybe luiz should work at msft? ibm for the infrastructure and msft for the software.....netvista?
now msft announces microsoft fabric.....sounds like v ip and some 8 magic?
that would be nice.
gemiini responded:
"what is microsoft fabric?


wadegarret wadegarret 12 minutos hace
PSIX extreme volatility is risky

Last quarter, you could buy every dip with confidence, as the stock came back within hours or days every time, and then made new highs. This time the stock just went from $35 to $15, which already is crazy, and now back to $22, which is nowhere near
TMaga TMaga 12 minutos hace
What was the nine day meeting all about? Send in an application for what??? Clinical trials (can take years) Patent application (Can take up to a year) Either is time consuming and doesn't guarantee acceptance. It is just the first step.
ADHC

Su Consulta Reciente

Delayed Upgrade Clock